1 Introduction to Research & Analysis Reports
1.1 Bacille Calmette-Guerin Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bacille Calmette-Guerin Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bacille Calmette-Guerin Vaccine Overall Market Size
2.1 Global Bacille Calmette-Guerin Vaccine Market Size: 2022 VS 2029
2.2 Global Bacille Calmette-Guerin Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bacille Calmette-Guerin Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Bacille Calmette-Guerin Vaccine Players in Global Market
3.2 Top Global Bacille Calmette-Guerin Vaccine Companies Ranked by Revenue
3.3 Global Bacille Calmette-Guerin Vaccine Revenue by Companies
3.4 Global Bacille Calmette-Guerin Vaccine Sales by Companies
3.5 Global Bacille Calmette-Guerin Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bacille Calmette-Guerin Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bacille Calmette-Guerin Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bacille Calmette-Guerin Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Bacille Calmette-Guerin Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Bacille Calmette-Guerin Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Bacille Calmette-Guerin Vaccine Market Size Markets, 2022 & 2029
4.1.2 Immune
4.1.3 Therapy
4.2 By Type – Global Bacille Calmette-Guerin Vaccine Revenue & Forecasts
4.2.1 By Type – Global Bacille Calmette-Guerin Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Bacille Calmette-Guerin Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Bacille Calmette-Guerin Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Bacille Calmette-Guerin Vaccine Sales & Forecasts
4.3.1 By Type – Global Bacille Calmette-Guerin Vaccine Sales, 2018-2023
4.3.2 By Type – Global Bacille Calmette-Guerin Vaccine Sales, 2024-2029
4.3.3 By Type – Global Bacille Calmette-Guerin Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Bacille Calmette-Guerin Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bacille Calmette-Guerin Vaccine Market Size, 2022 & 2029
5.1.2 Private Distribution Channel
5.1.3 Public Distribution Channel
5.2 By Application – Global Bacille Calmette-Guerin Vaccine Revenue & Forecasts
5.2.1 By Application – Global Bacille Calmette-Guerin Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Bacille Calmette-Guerin Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Bacille Calmette-Guerin Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Bacille Calmette-Guerin Vaccine Sales & Forecasts
5.3.1 By Application – Global Bacille Calmette-Guerin Vaccine Sales, 2018-2023
5.3.2 By Application – Global Bacille Calmette-Guerin Vaccine Sales, 2024-2029
5.3.3 By Application – Global Bacille Calmette-Guerin Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Bacille Calmette-Guerin Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Bacille Calmette-Guerin Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Bacille Calmette-Guerin Vaccine Revenue & Forecasts
6.2.1 By Region – Global Bacille Calmette-Guerin Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Bacille Calmette-Guerin Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Bacille Calmette-Guerin Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Bacille Calmette-Guerin Vaccine Sales & Forecasts
6.3.1 By Region – Global Bacille Calmette-Guerin Vaccine Sales, 2018-2023
6.3.2 By Region – Global Bacille Calmette-Guerin Vaccine Sales, 2024-2029
6.3.3 By Region – Global Bacille Calmette-Guerin Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Bacille Calmette-Guerin Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Bacille Calmette-Guerin Vaccine Sales, 2018-2029
6.4.3 US Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.4.4 Canada Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.4.5 Mexico Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Bacille Calmette-Guerin Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Bacille Calmette-Guerin Vaccine Sales, 2018-2029
6.5.3 Germany Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5.4 France Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5.5 U.K. Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5.6 Italy Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5.7 Russia Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.5.9 Benelux Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Bacille Calmette-Guerin Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Bacille Calmette-Guerin Vaccine Sales, 2018-2029
6.6.3 China Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.6.4 Japan Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.6.5 South Korea Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.6.7 India Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Bacille Calmette-Guerin Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Bacille Calmette-Guerin Vaccine Sales, 2018-2029
6.7.3 Brazil Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.7.4 Argentina Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Bacille Calmette-Guerin Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Bacille Calmette-Guerin Vaccine Sales, 2018-2029
6.8.3 Turkey Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.8.4 Israel Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
6.8.6 UAE Bacille Calmette-Guerin Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Bacille Calmette-Guerin Vaccine Major Product Offerings
7.1.4 Merck Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Company Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Major Product Offerings
7.2.4 Sanofi Pasteur Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi Pasteur Key News & Latest Developments
7.3 Japan BCG Lab
7.3.1 Japan BCG Lab Company Summary
7.3.2 Japan BCG Lab Business Overview
7.3.3 Japan BCG Lab Bacille Calmette-Guerin Vaccine Major Product Offerings
7.3.4 Japan BCG Lab Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Japan BCG Lab Key News & Latest Developments
7.4 China National Biotec
7.4.1 China National Biotec Company Summary
7.4.2 China National Biotec Business Overview
7.4.3 China National Biotec Bacille Calmette-Guerin Vaccine Major Product Offerings
7.4.4 China National Biotec Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 China National Biotec Key News & Latest Developments
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Summary
7.5.2 Serum Institute of India Business Overview
7.5.3 Serum Institute of India Bacille Calmette-Guerin Vaccine Major Product Offerings
7.5.4 Serum Institute of India Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute of India Key News & Latest Developments
7.6 Intervax
7.6.1 Intervax Company Summary
7.6.2 Intervax Business Overview
7.6.3 Intervax Bacille Calmette-Guerin Vaccine Major Product Offerings
7.6.4 Intervax Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Intervax Key News & Latest Developments
7.7 GSBPL
7.7.1 GSBPL Company Summary
7.7.2 GSBPL Business Overview
7.7.3 GSBPL Bacille Calmette-Guerin Vaccine Major Product Offerings
7.7.4 GSBPL Bacille Calmette-Guerin Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 GSBPL Key News & Latest Developments
8 Global Bacille Calmette-Guerin Vaccine Production Capacity, Analysis
8.1 Global Bacille Calmette-Guerin Vaccine Production Capacity, 2018-2029
8.2 Bacille Calmette-Guerin Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Bacille Calmette-Guerin Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bacille Calmette-Guerin Vaccine Supply Chain Analysis
10.1 Bacille Calmette-Guerin Vaccine Industry Value Chain
10.2 Bacille Calmette-Guerin Vaccine Upstream Market
10.3 Bacille Calmette-Guerin Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bacille Calmette-Guerin Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のカルメットゲラン桿菌ワクチン市場予測2023-2029：免疫用、治療用 |
| 【英語タイトル】Bacille Calmette-Guerin Vaccine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5705 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：75 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のカルメットゲラン桿菌ワクチン市場規模と予測を収録しています。・世界のカルメットゲラン桿菌ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のカルメットゲラン桿菌ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のカルメットゲラン桿菌ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫用」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 カルメットゲラン桿菌ワクチンのグローバル主要企業は、Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 Serum Institute of India、 Intervax、 GSBPLなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、カルメットゲラン桿菌ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のカルメットゲラン桿菌ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のカルメットゲラン桿菌ワクチン市場：タイプ別市場シェア、2022年 ・免疫用、治療用 世界のカルメットゲラン桿菌ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のカルメットゲラン桿菌ワクチン市場：用途別市場シェア、2022年 ・民間流通チャネル、公共流通チャネル 世界のカルメットゲラン桿菌ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のカルメットゲラン桿菌ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるカルメットゲラン桿菌ワクチンのグローバル売上、2018年-2023年 ・主要企業におけるカルメットゲラン桿菌ワクチンのグローバル売上シェア、2022年 ・主要企業におけるカルメットゲラン桿菌ワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるカルメットゲラン桿菌ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 Serum Institute of India、 Intervax、 GSBPL ************************************************************* ・調査・分析レポートの概要 カルメットゲラン桿菌ワクチン市場の定義 市場セグメント 世界のカルメットゲラン桿菌ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のカルメットゲラン桿菌ワクチン市場規模 世界のカルメットゲラン桿菌ワクチン市場規模：2022年 VS 2029年 世界のカルメットゲラン桿菌ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのカルメットゲラン桿菌ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のカルメットゲラン桿菌ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：免疫用、治療用 カルメットゲラン桿菌ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：民間流通チャネル、公共流通チャネル カルメットゲラン桿菌ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別カルメットゲラン桿菌ワクチン市場規模 2022年と2029年 地域別カルメットゲラン桿菌ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Merck、 Sanofi Pasteur、 Japan BCG Lab、 China National Biotec、 Serum Institute of India、 Intervax、 GSBPL ... |
Bacille Calmette-Guerin Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys.
This report aims to provide a comprehensive presentation of the global market for Bacille Calmette-Guerin Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacille Calmette-Guerin Vaccine. This report contains market size and forecasts of Bacille Calmette-Guerin Vaccine in global, including the following market information:
Global Bacille Calmette-Guerin Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bacille Calmette-Guerin Vaccine Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Bacille Calmette-Guerin Vaccine companies in 2022 (%)
The global Bacille Calmette-Guerin Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immune Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bacille Calmette-Guerin Vaccine include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax and GSBPL, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bacille Calmette-Guerin Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bacille Calmette-Guerin Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bacille Calmette-Guerin Vaccine Market Segment Percentages, by Type, 2022 (%)
Immune
Therapy
Global Bacille Calmette-Guerin Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bacille Calmette-Guerin Vaccine Market Segment Percentages, by Application, 2022 (%)
Private Distribution Channel
Public Distribution Channel
Global Bacille Calmette-Guerin Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bacille Calmette-Guerin Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bacille Calmette-Guerin Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bacille Calmette-Guerin Vaccine revenues share in global market, 2022 (%)
Key companies Bacille Calmette-Guerin Vaccine sales in global market, 2018-2023 (Estimated), (Units)
Key companies Bacille Calmette-Guerin Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bacille Calmette-Guerin Vaccine, market overview.
Chapter 2: Global Bacille Calmette-Guerin Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Bacille Calmette-Guerin Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bacille Calmette-Guerin Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bacille Calmette-Guerin Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のカルメットゲラン桿菌ワクチン市場予測2023-2029：免疫用、治療用] (コード：MMG23JU5705)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のカルメットゲラン桿菌ワクチン市場予測2023-2029：免疫用、治療用]についてメールでお問い合わせ |
